EU eHealth Competition 2017

The eHealth Competition is an initiative that rewards the best eHealth / mHealth solutions produced by European SMEs (Small and Medium Enterprises). Its objective is to support business success of SMEs by giving them visibility together with marketing opportunities to attract customers, partners and external capital.

The EU eHealth Competition final 2017 will be held in Barcelona, on the 3rd of May, in cooperation with Health 2.0 and Healthio.

The novelty this year is the launch of a Diabetes track to reward the best solutions for the population management of the disease. This track is aligned to the ProEmpower initiative (Pre-commercial Procurement). You can also submit your proposal to the ProEmpower call in september 2017. Companies that reach the final phase will receive up to 1,140,000 €.

The calls for EU eHealth Competition and ProEmpower are completely independent. EU eHealth Competition deadline is 6th March 2017.

SME eligibility criteria (all apply):

  • The SME has to have a VAT number.
  • The SME headquarters have to be located in Europe (see below eligible countries).
  • Headcount less than 150 employees.
  • Annual turnover of less than 5.000.000 euros.
  • The company cannot belong to a large conglomerate or being subsidiary of a multinational.
The criteria above must be fulfilled at the time of registration.

For further information about EU eHealth Competition 2017, please visit: https://www.ehealthcompetition.eu

For further information about the ProEmpower call, please visit:
http://www.proempower-pcp.eu

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...